Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Avalo Therapeutics, Inc. Filed Acc 0000919574-26-008106

Stakes reported in this filing

Reporting person Shares Of the class
Point72 Asset Management, L.P. 1,625,019 3.0%
Point72 Capital Advisors, Inc. 1,625,019 3.0%
Steven A. Cohen 1,625,019 3.0%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…